Pacific Edge Named in Tin100 Top 10 List
20 October 2016
Pacific Edge Named in Tin100 Top 10 List; Now Part of Tricare Health Plan Network
The growing success of cancer diagnostics company Pacific Edge has once again been recognised with company named in the 2016 TIN100 Top Ten list of Hot Emerging Companies for the second year in a row.
TIN Managing Director Greg Shanahan said: "This year's Ten Hot Emerging Companies in the TIN100 Report are an exceptionally high-performing group. These ten companies almost doubled the record performance of the companies on last year's list with a continued revenue growth of over $61 million (or 138%).
The US is a major market for a number of the high growth companies named at the event in Auckland last night, including Pacific Edge.
Pacific Edge has identified the US, the world’s biggest healthcare market, as its largest opportunity for its innovative bladder cancer diagnostics tests, and also has a number of other targeted international markets, including New Zealand, Australia and South East Asia.
Meanwhile, Pacific Edge Limited’s US subsidiary is now an approved provider as part of the TRICARE Health Plan network, which provides healthcare coverage to approximately 9.4 million beneficiaries around the world under the US Military Health System including active military and veterans.
Chief Executive of Pacific Edge David Darling said: “We are gaining more and more recognition of our Cxbladder tests as an effective, accurate and simple-to-use, non-invasive test for the diagnosis and monitoring of bladder cancer. This latest provider approval is a reflection of our growing traction in the USA and increases our penetration into this key market.”